Phase III Precision Medicine Clinical Trial Designs That Integrate Treatment and Biomarker Evaluation.

MLA

Polley, Mei-Yin C., et al. “Phase III Precision Medicine Clinical Trial Designs That Integrate Treatment and Biomarker Evaluation.” JCO Precision Oncology, vol. 3, Oct. 2019, pp. 1–9. EBSCOhost, https://doi.org/10.1200/PO.18.00416.

APA

Polley, M.-Y. C., Korn, E. L., & Freidlin, B. (2019). Phase III Precision Medicine Clinical Trial Designs That Integrate Treatment and Biomarker Evaluation. JCO Precision Oncology, 3, 1–9. https://doi.org/10.1200/PO.18.00416

Chicago

Polley, Mei-Yin C., Edward L. Korn, and Boris Freidlin. 2019. “Phase III Precision Medicine Clinical Trial Designs That Integrate Treatment and Biomarker Evaluation.” JCO Precision Oncology 3 (October): 1–9. doi:10.1200/PO.18.00416.